# Robust effector memory features of human T-bethi B cells induced by repeated mRNA vaccination

**Authors:** Jeongsoo Lee, Seunghwan Son, Youseung Chung, Sung-Dong Cho, Ji-Soo Kwon, Seongman Bae, Joon Seok, Baekgyu Choi, Inkyung Jung, Ji Eun Oh, Eui-Cheol Shin, Sung-Han Kim, Su-Hyung Park

PMC · DOI: 10.1016/j.isci.2026.114804 · iScience · 2026-01-27

## TL;DR

Repeated mRNA vaccination creates a special type of B cell that quickly produces virus-fighting antibodies, improving immune memory.

## Contribution

Identifies T-bethi B cells as a distinct, functionally potent subset induced by repeated mRNA vaccination.

## Key findings

- T-bethi B cells are marked by CD11c, FcRL5, and T-bet gene activity.
- These B cells rapidly become antibody-secreting cells with high neutralizing power.
- They show affinity maturation and contribute to early immune recall responses.

## Abstract

The heterogeneity of memory B cells in response to repetitive cognate antigen challenges remains to be fully elucidated. Here, we identified a transcriptionally distinct cluster of T-bethi B cells, among SARS-CoV-2 RBD-specific B cells in PBMCs from healthy individuals vaccinated with the BNT162b2 SARS-CoV-2 mRNA vaccine. Our findings indicate that T-bethi B cells can be defined by a combination of CD11c and FcRL5 receptors, and are distinguished by distinct gene regulatory networks associated with effector functions. Notably, these T-bethi B cells were affinity-matured and exhibited rapid differentiation into antibody-secreting cells (ASCs) producing neutralizing antibodies comparable to classical memory B cells, underscoring their role in early recall responses. Taken together, these findings illuminate the potent effector memory roles of T-bethi B cells in adaptive immunity following vaccinations.

•Repeated vaccination induces affinity-matured T-bethi B cells with effector traits•Vaccine-induced T-bethi B cells are defined by CD11c, FcRL5, and a T-bet gene network•T-bethi B cells rapidly form neutralizing antibody-secreting cells upon recall

Repeated vaccination induces affinity-matured T-bethi B cells with effector traits

Vaccine-induced T-bethi B cells are defined by CD11c, FcRL5, and a T-bet gene network

T-bethi B cells rapidly form neutralizing antibody-secreting cells upon recall

Immunology; Immune response; Virology

## Linked entities

- **Genes:** TBX21 (T-box transcription factor 21) [NCBI Gene 30009]
- **Proteins:** ITGAX (integrin subunit alpha X), FCRL5 (Fc receptor like 5)
- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, PRDM1 (PR/SET domain 1) [NCBI Gene 639] {aka BLIMP-1, BLIMP1, PRDI-BF1}, LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859] {aka CD85J, ILT-2, ILT2, LIR-1, LIR1, MIR-7}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}, ZEB2 (zinc finger E-box binding homeobox 2) [NCBI Gene 9839] {aka HSPC082, SIP-1, SIP1, SMADIP1, ZFHX1B}, Cd27 (CD27 antigen) [NCBI Gene 21940] {aka S152, Tnfrsf7, Tp55}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, ZMYND10 (zinc finger MYND-type containing 10) [NCBI Gene 51364] {aka BLU, CILD22, DNAAF7, FLU}, TBX21 (T-box transcription factor 21) [NCBI Gene 30009] {aka IMD88, T-PET, T-bet, TBET, TBLYM}, OR6V1 (olfactory receptor family 6 subfamily V member 1) [NCBI Gene 346517] {aka GPR138}, FCGR2B (Fc gamma receptor IIb) [NCBI Gene 2213] {aka CD32, CD32B, FCG2, FCGR2, IGFR2}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, Cd19 (CD19 antigen) [NCBI Gene 12478], Bcr (BCR activator of RhoGEF and GTPase) [NCBI Gene 110279] {aka 5133400C09Rik, mKIAA3017}, Ncam1 (neural cell adhesion molecule 1) [NCBI Gene 17967] {aka CD56, E-NCAM, NCAM-1, Ncam}, CR2 (complement C3d receptor 2) [NCBI Gene 1380] {aka C3DR, CD21, CR, CVID7, SLEB9}, Cd14 (CD14 antigen) [NCBI Gene 12475], GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}, IRF9 (interferon regulatory factor 9) [NCBI Gene 10379] {aka IRF-9, ISGF3, ISGF3G, p48}, ELF4 (E74 like ETS transcription factor 4) [NCBI Gene 2000] {aka AIFBL2, ELFR, MEF}, IRF4 (interferon regulatory factor 4) [NCBI Gene 3662] {aka IMD131, LSIRF, MUM1, NF-EM5, SHEP8}, Cd38 (CD38 antigen) [NCBI Gene 12494] {aka ADPRC 1, Cd38-rs1, I-19}, ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, FCRL5 (Fc receptor like 5) [NCBI Gene 83416] {aka BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820}, Ighd (immunoglobulin heavy constant delta) [NCBI Gene 380797] {aka IgD, Igh-5}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, BACH2 (BACH transcriptional regulator 2) [NCBI Gene 60468] {aka BTBD25, IMD60}, XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}, Fcrl5 (Fc receptor-like 5) [NCBI Gene 329693] {aka Fcrh3, mBXMH2}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}
- **Diseases:** hypersensitivity (MESH:D004342), tetanus (MESH:D013746), infectious diseases (MESH:D003141), malaria (MESH:D008288), HIV infection (MESH:D015658), viral infections (MESH:D014777), infection (MESH:D007239), COVID-19 (MESH:D000086382), AIDS (MESH:D000163), autoimmune diseases (MESH:D001327), SLE (MESH:D008180), diseases (MESH:D004194), inflammation (MESH:D007249), hepatitis C (MESH:D019698)
- **Chemicals:** R848 (MESH:C402365), dimethyl sulfoxide (MESH:D004121), PBS (MESH:D007854), PVDF (MESH:C024865), Cy7 (-), nitro blue tetrazolium (MESH:D009580), biotin (MESH:D001710), oligonucleotide (MESH:D009841), 5-bromo-4-chloro-3-indolyl-phosphate (MESH:C035455), TMB (MESH:C021758), EDTA (MESH:D004492), nitrogen (MESH:D009584)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** D14 T
- **Cell lines:** Wuhan-Hu-1 — Homo sapiens (Human), Finite cell line (CVCL_B0BH), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915279/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915279/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915279/full.md

---
Source: https://tomesphere.com/paper/PMC12915279